Aa
A
A
Close
Avatar_universal
HCV Polymerase Inhibitor VX-222 Demonstrates Good Safety and Antiviral Activity in Treatment-naive Genotype 1 Hepatitis C Patients
SUMMARY: The experimental hepatitis C virus (HCV) polymerase inhibitor VX-222, being developed by Vertex, was generally well-tolerated and exhibited good antiviral activity over 3 days across a range of doses in treatment-naive genotype 1 patients, according to a Phase 1b study presented last week at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010) in Vienna.

http://hcvadvocate.org/news/newsRev/2010/NewsRev-359.html#_HCV_Polymerase_Inhibitor
Cancel
8 Answers
Page 1 of 1
Avatar_universal
Vertex is experimenting with the newly developed polymerase inhibitor VX-222.  It seems to have a potent antiviral effect after 3 days!

The study included 32 naive genotype 1 patients. Looks like there was an average RNA HEP C VIRAL PCR QUAN decline of >3log10 at day 4.  There was a a HCV RNA viral load decrease of at least 3 log IU/mL in everyone.  

Pegylated Interferon alfa-2a + Ribavirin + Telaprevir = virus eradication even in prior non responders!



Comment
Cancel
Avatar_universal
Comment
Comment
Submit Comment
Avatar_universal
Most PI`s do have that effect,they knock the virus out within days,and keep it out
Comment
Cancel
Avatar_universal
Comment
Comment
Submit Comment
Avatar_universal
So why is it gonna take 10 years for us to get our hands on it?
Comment
Cancel
Avatar_universal
Comment
Comment
Submit Comment
Avatar_universal
Dont want to sound negative,but just maybe the drug is too good,with the cure rates well over 80% this means there will be no almost noboby left with this disease if everybody treats with all the new P` drugs.If this drug is goona wipe out the hepatitis,the drug companys have just a one shot kinda deal to make big cash,so i bet they might be charging and arm and a leg for it,when it finaly hits the public....just my thoughts..seems like they are not telling us too much on the releqase dates
Comment
Cancel
Avatar_universal
Comment
Comment
Submit Comment
1113735_tn?1273178030
Yes, Rocker, I agree, seems like we will have to wait for a new med, or they will have to invent a new "uncurable " desease :)
Comment
Cancel
1113735_tn?1273178030
Comment
Comment
Submit Comment
Avatar_universal
Here's this article if you haven't seen it already.  I posted it on an earlier thread.  It kind of gives a brief overview on what is expected to happen release date wise for a lot of the new developing drugs.  Thought it was interesting.  

http://pubs.acs.org/cen/coverstory/88/8818cover.html

Researchers expect three waves of small-molecule drug approvals, each of which will improve HCV treatment. First, telaprevir and boceprevir are likely to be approved next year as add-ons to the current treatment regimen. The second wave, in three to five years, will bring second-generation protease blockers, a crop of polymerase inhibitors, and new classes of compounds such as Bristol-Myers Squibb’s NS5A inhibitor and Debiopharm’s cyclophilin inhibitor. Finally, researchers hope that in the next five to 10 years they will reach the ultimate goal—enough data to convince doctors and the Food & Drug Administration that the virus can be quieted with combinations of small molecules alone.


Comment
Cancel
Avatar_universal
Comment
Comment
Submit Comment
29837_tn?1414538248
Only problem here is, with all the new drugs being tested, they always mention "naive". What about the null responders? I say let's not uncork the champagne yet...

Magnum
Comment
Cancel
29837_tn?1414538248
Comment
Comment
Submit Comment
Avatar_universal
I cant understand why the drug companys wont help the ones who need it most right now,this will save money on transplant costs and even help to stop the spread of this disease,im sure they will have trials geared  to non-null responders coming along too,but it does seem like they are taking thier sweet a,ss time.Where is the this fast track they talk about?Its not like they will go broke helping out the ones who need it now,like the stage 3-4 people...we all know by now the PI` s are workn and safe...im still alive after almost one year post and SVR after the bocep
Comment
Cancel
Avatar_universal
Comment
Comment
Submit Comment
Your Answer
Avatar_universal
Answer
Know how to answer? Tap here to leave your answer...
Answer
HCV Polymerase Inhibitor VX-222 Demonstrates Good Safety and Antiviral Activity in Treatment-naive Genotype 1 Hepatitis C Patients
Submit Answer
A
A
Recent Activity
Avatar_universal
Blank
susan400 Just diagnosed w/Graves..st... Comment
1 hr ago
4059843_tn?1454481984
Blank
mishymoshymarcy commented on need a title -
17 hrs ago
134578_tn?1446090952
Blank
AnnieBrooke commented on need a title -
17 hrs ago
Blank
Weight Tracker
Track your weight over time
Start Tracking Now
Top Hepatitis Answerers
446474_tn?1446351282
Blank
HectorSF
San Francisco, CA
1815939_tn?1377995399
Blank
pooh55811
317787_tn?1428318779
Blank
Dee1956
DC
Avatar_m_tn
Blank
can-do-man
IN
163305_tn?1333672171
Blank
orphanedhawk
Rural Mural, CA
683231_tn?1438659664
Blank
flyinlynn
Auburn, WA
Hepatitis C Community Resources
RSS Expert Activity
233488_tn?1310696703
Blank
Marathon Running Done Over Many Yea...
May 21 by John C Hagan III, MD, FACS, FAAOBlank
233488_tn?1310696703
Blank
New Article on Multifocal IOL vs &q...
May 21 by John C Hagan III, MD, FACS, FAAOBlank
748543_tn?1443740527
Blank
TMJ/TMJ The Connection Between Teet...
01/15 by Hamidreza Nassery , DMD, FICOI, FAGD, FICCMOBlank
Top Hepatitis Answerers
446474_tn?1446351282
Blank
HectorSF
San Francisco, CA
1815939_tn?1377995399
Blank
pooh55811
317787_tn?1428318779
Blank
Dee1956
DC
Avatar_m_tn
Blank
can-do-man
IN
163305_tn?1333672171
Blank
orphanedhawk
Rural Mural, CA
683231_tn?1438659664
Blank
flyinlynn
Auburn, WA